Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nemonoxacin in Moderate Hepatic Impairment
NCT02604498Phase 1Completed
- Sponsor
- Zhejiang Medicine Co., Ltd.
- Start
- Apr 2016
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of nemonoxacin in community acquired pneumonia (CAP) (2 arms), sponsored by Zhejiang Medicine Co., Ltd. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Concentration and 7 more. Started Apr 2016; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT02604498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02604498.